Sanctuary Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
7,267
+1,378
+23% +$49.6K ﹤0.01% 2488
2026
Q1
$208K Sell
5,889
-1,446
-20% -$58.8K ﹤0.01% 2352
2025
Q4
$298K Buy
7,335
+652
+10% +$28.4K ﹤0.01% 2021
2025
Q3
$314K Sell
6,683
-4,662
-41% -$242K ﹤0.01% 1978
2025
Q2
$591K Sell
11,345
-4,743
-29% -$260K ﹤0.01% 1533
2025
Q1
$972K Sell
16,088
-337
-2% -$21.7K 0.01% 1142
2024
Q4
$1.16M Buy
16,425
+2,568
+19% +$179K 0.01% 1166
2024
Q3
$1.04M Sell
13,857
-15
-0.1% -$1.06K 0.01% 1232
2024
Q2
$913K Buy
+13,872
New +$1.01M 0.01% 1252

Other funds holding CNMD

Sanctuary Advisors's CNMD Position: Q2 2026 in Review

Sanctuary Advisors increased its CONMED (CNMD) stake by 23% in Q2 2026, buying an estimated $49.6K and bringing the position to 7,267 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Sanctuary Advisors first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.16M in Q4 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Sanctuary Advisors held 7,267 shares of CONMED worth $238K as of Q2 2026.
  • Sanctuary Advisors bought 1,378 CONMED shares in Q2 2026, an estimated $49.6K.
  • CONMED made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2488 holding.
  • Sanctuary Advisors first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's CONMED position peaked at $1.16M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.